APRIL 2023 / NOSTRUM BIODISCOVERY TAKES PART IN THE AMBITIOUS MDDB EUROPEAN PROJECT TO CREATE THE FIRST DATABASE OF MOLECULAR DYNAMICS.
Nostrum Biodiscovery is one of the key partners in the ambitious european MDDB project, which was officially launched last 24-25th of april in Barcelona.
Researchers led by Dr. Modesto Orozco, co-funder and president of Nostrum Biodiscovery, and head of the Molecular Modelling and Bioinformatics lab at IRB Barcelona, aim to develop the first European database of molecular dynamics. In the upcoming three years, the scientists will establish the groundwork for an infrastructure that enhances the use of computational resources, enables data analysis from multiple perspectives, ensures rapid and efficient information exchange among various institutions, and promotes the incorporation of molecular dynamics into other research domains.
The project has received €3.3 million in funding and brings together several institutions including the IRB Barcelona, Barcelona Supercomputing Center (BSC CNS), the European Molecular Biology Laboratory (EMBL), the European Center for Atomic and Molecular Calculations (CECAM) of the Swiss Federal Institute of Technology Lausanne, the KTH Royal Institute of Technology in Stockholm, and the University of Oxford (UOXF).
Here at Nostrum Biodiscovery, our expertise in molecular dynamics data production and use makes us an essential contributor to the project.
The goal of the project is to establish an infrastructure that optimizes computational resources, supports data analysis from different perspectives, promotes efficient information exchange, and facilitates the integration of molecular dynamics into other research fields. The database could have a significant impact on research in fields such as biochemistry, pharmacology, personalized medicine, chemistry, and nanotechnology. The project will run for three years and is supported by various organizations, including the European Commission’s Horizon Europe program, UK Research and Innovation, and the Swiss State Secretariat for Education, Research and Innovation.
This project has received funding from the European Union’s Horizon Europe programme under grant agreement 101094651.
About Nostrum Biodiscovery
Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB), two of the most recognized Spanish international research centers.
Nostrum Biodiscovery provide advanced technologies in Molecular Modelling, with two areas of focus : therapeutics, e.g. small molecules design, targeted protein degradation, antibodies, immunologics and nucleic acids, and bio-based chemistry as in enzyme engineering.
Nostrum Biodiscovery’s customer-tailored solutions are based on state-of-the-art proprietary and 3rd-party software, combined with the latest development on AI. We use best in-class Molecular Modeling for data augmentation and fine-tuning of dedicated machine-learning algorithms.
With a focus on efficiency, innovation, and accessibility, Nostrum Biodiscovery is committed to providing cutting-edge solutions to the global scientific community.